Nitroreductase (NTR) is widely regarded as a biomarker whose enzymatic activity correlates with the degree of hypoxia in solid malignant tumors. Herein, we utilized 2-dimethylamino-7-hydroxynaphthalene as fluorophore linked diverse nitroaromatic groups to obtain four NTR-activatable two-photon fluorescent probes based on covalent assembly strategy. With the help of computer docking simulation and in vitro assay, the sulfonate-based probe XN3 was proved to be able to identify NTR activity with best performances in rapid response, outstanding specificity, and sensitivity in comparison with the other three probes. Furthermore, XN3 could detect the degree of hypoxia by monitoring NTR activity in kinds of cancer cells with remarkable signal-to-noise ratios. In cancer tissue sections of the breast and liver in mice, XN3 had the ability to differentiate between healthy and tumorous tissues, and possessed excellent fluorescence stability, high tissue penetration and low tissue autofluorescence. Finally, XN3 was successfully utilized for in situ visualizing NTR activities in human transverse colon and rectal cancer tissues, respectively. The findings suggested that XN3 could directly identify the boundary between cancer and normal tissues by monitoring NTR activities, which provides a new method for imaging diagnosis and intraoperative navigation of tumor tissue.
Keyphrases
- living cells
- fluorescent probe
- endothelial cells
- papillary thyroid
- single molecule
- gene expression
- rectal cancer
- squamous cell
- small molecule
- fluorescence imaging
- quantum dots
- high resolution
- induced pluripotent stem cells
- metabolic syndrome
- high throughput
- patients undergoing
- locally advanced
- molecular dynamics
- squamous cell carcinoma
- childhood cancer
- hydrogen peroxide
- photodynamic therapy
- machine learning
- air pollution
- insulin resistance
- radiation therapy
- label free